← Open Payments lookup

SUZANNE O'BRIEN: Open Payments

NPI 1730735564 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,414 in 167 payments from 14 companies in 2025. Trend: 2023 $441 · 2024 $1,718 · 2025 $2,414

Food & beverage: $2,414
CompanyPaymentsAmount
Alkermes, Inc.21$511
Neurocrine BioSciences, Inc.23$334
ABBVIE INC.39$333
Otsuka America Pharmaceutical, Inc.22$295
E.R. Squibb & Sons, L.L.C.20$223
Teva Pharmaceuticals USA, Inc.10$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$157
Vanda Pharmaceuticals Inc.8$139
Lundbeck LLC5$92
Janssen Pharmaceuticals, Inc3$53

Products named: INGREZZA, VRAYLAR, ARISTADA, REXULTI, COBENFY, CAPLYTA, LYBALVI, FANAPT.

Industry payments across NJ — which companies pay providers there.